All national dailies wrote that Fujifilm Holdings Corp. said on Wednesday that it will submit to the Health Ministry as early as October a request of approval for its antivirus drug Avigan to treat patients infected with the novel coronavirus, as clinical tests for the drug have demonstrated efficacy in easing symptoms. The papers wrote that the ministry may approve the drug as early as the end of this year. If approved, Avigan will be the third drug to be approved for COVID-19 treatment in Japan, following remdesivir and dexamethasone.